{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Acetamide", "Dexamesathone", "Liver functions", "Quinazoline", "Ulcerative colitis", "Ulcers"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "29379346", "DateRevised": {"Year": "2022", "Month": "02", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "09", "Day": "28"}], "Language": ["eng"], "ELocationID": ["10.1016/j.jsps.2017.09.011"], "Journal": {"ISSN": "1319-0164", "JournalIssue": {"Volume": "26", "Issue": "1", "PubDate": {"Year": "2018", "Month": "Jan"}}, "Title": "Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society", "ISOAbbreviation": "Saudi Pharm J"}, "ArticleTitle": "Novel quinazoline and acetamide derivatives as safe anti-ulcerogenic agent and anti-ulcerative colitis activity.", "Pagination": {"StartPage": "138", "EndPage": "143", "MedlinePgn": "138-143"}, "Abstract": {"AbstractText": ["Two novel quinazoline derivatives named as; 3-[(4-hydroxy-3-methoxy-benzylidene)-amino]-2-<i>p-</i>tolyl-3<i>H</i>-quinazolin-4-one (<b>5</b>) and 2-<i>p</i>-Tolyl-3-[3,4,5-trimethoxy-benzylidene-amino]-3<i>H</i>-quinazolin-4-one (<b>6</b>) in addition to one acetamide derivative named as 2-(2-Hydroxycarbonylphenylamino)-<i>N</i>-(4-aminosulphonylphenyl) <b>11</b> were synthesized, and evaluated for their anti-ulcerogenic & Anti-Ulcerative colitis activities. All of the three compounds showed curative activity against acetic acid induced ulcer model at a dose of 50\u00a0mg/kg, they produced 65%, 85% & 57.74% curative ratio for compounds <b>5</b>, <b>6</b> & <b>11</b> respectively. The effect of the tested compounds <b>5</b>, <b>6</b> & <b>11</b> at dose 50\u202fmg/kg were significantly (P\u00a0<\u00a00.01) more effective than dexamesathone (0.1\u202fmg/kg) in reducing all parameters. Compounds showed curative activity of for peptic ulcer (induced by absolute alcohol (at a dose of 50\u202fmg/kg, it produced Curative of control ulcer 56.00%, 61.70% & 87.1% for compounds <b>5</b>, <b>6</b> & <b>11</b> respectively at dose 50\u202fmg/kg, while the standard drug (Omeprazole 20\u202fmg/kg) produced 33.3%. In both tests, the activity of our target compounds were higher than the standard drugs used for treatment of peptic ulcer and ulcerative colitis. No side effects were reported on liver and kidney functions upon prolonged oral administration of this compounds."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Department, College of Science, King Saud University, Riyadh 11362, Saudi Arabia."}], "LastName": "Alasmary", "ForeName": "Fatmah A S", "Initials": "FAS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy Department, College of Pharmacy, Sattam bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia."}], "LastName": "Awaad", "ForeName": "Amani S", "Initials": "AS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Kulliyyah of Science, International Islamic University Malaysia, Malaysia."}], "LastName": "Alafeefy", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Aromatic and Medicinal Plants Department, Desert Research Center, Cairo, Egypt."}], "LastName": "El-Meligy", "ForeName": "Reham M", "Initials": "RM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, College of Pharmacy, King Saud University, KSA."}], "LastName": "Alqasoumi", "ForeName": "Saleh I", "Initials": "SI"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Saudi Arabia", "MedlineTA": "Saudi Pharm J", "NlmUniqueID": "9705695", "ISSNLinking": "1319-0164"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Autore G., Caruso A., Marzocco S., Nicolaus B., Palladino C., Pinto A., Popolo A., Sinicropi M.S., Tommonaro G., Saturnino C. Acetamide derivatives with antioxidant activity and potential anti-inflammatory activity. Molecules. 2010;15:2028.", "ArticleIdList": ["PMC6257181", "20336030"]}, {"Citation": "Awaad A.S., Al-Jaber N.A., Moses J.E., El-Meligy R.M., Zain M.E. Antiulcerogenic activities of the extracts and isolated flavonoids of Euphorbia Cuneata Vahl. Phytother. Res. 2013;27:126\u2013130.", "ArticleIdList": ["23097351"]}, {"Citation": "Awaad A.S., El-Meligy R.M., Al-Jaber N.A., Al-Muteeri H.S., Zain M.E., Alqasoumi S.I., Alafeefy A.M., Donia A.E.R.M. Anti-ulcerative colitis activity of compounds from Euphorbia Granuleta Forssk. Phytother. Res. 2013;27:1729\u20131734.", "ArticleIdList": ["23580316"]}, {"Citation": "Awaad A.S., El-Meligy R.M., Soliman G.A. Natural products in treatment of ulcerative colitis and peptic ulcer. J. Saudi Chem. Soc. 2013;17:101\u2013124."}, {"Citation": "Bighetti A.E., Antonio M.A., Kohn L.K., Rehder V.L., Foglio M.A., Possenti A., Vilela L., Carvalho J.E. Antiulcerogenic activity of a crude hydroalcoholic extract and coumarin isolated from Mikania Laevigata Schultz Bip. Phytomedicine. 2005;12:72\u201377.", "ArticleIdList": ["15693711"]}, {"Citation": "El-Meligy Reham M., Awaad Amani S., Soliman Gamal A., Kenawy Sanaa A., Alqasoumi Saleh I. Prophylactic and curative anti-ulcerogenic activity and the possible mechanisms of action of some desert plants. Saudi Pharm. J. 2017;25:387\u2013396.", "ArticleIdList": ["PMC5357099", "28344494"]}, {"Citation": "El-Meligy Reham M., Awaad Amani S., Soliman Gamal A., Bacha Abir B., Alafeefy Ahmed M., Kenawy Sanaa A. Prophylactic and curative anti-ulcerative colitis activity and the possible mechanisms of action of some desert plants. J. Enzyme Inhib. Med. Chem. 2011;30(2):250\u2013258.", "ArticleIdList": ["24811429"]}, {"Citation": "Ghorab Mostafa M., El-Gaby Mohamed S.A., Alsaid Mansour S., Elshaier Yaseen A.M.M., Soliman Aiten M., El-Senduny Fardous F., Badria Farid A. Novel thiourea derivatives bearing sulfonamide moiety as anticancer agents through COX-2 inhibition. Anticancer Agents Med. Chem. 2017;32(1):893\u2013907.", "ArticleIdList": ["28356021"]}, {"Citation": "Ghorab K., El-Massry T., Shibamoto S. Chemical composition of the volatile extract and antioxidant activities of the volatile and nonvolatile extracts of Egyptian corn silk (Zea mays L.) J. Agric. Food Chem. 2011;55(2007):9124\u20139127.", "ArticleIdList": ["17914872"]}, {"Citation": "Junek R., Kverka M., Jandera A., Panajotova V., \u0160atinsk\u00fd D., Mach\u00e1\u010dek M., Kucha\u0159 M. Antileukotrienic phenethylamido derivatives of arylalkanoic acids in the treatment of ulcerative colitis. Europ. J. Med. Chem. 2009;44:332\u2013344.", "ArticleIdList": ["18406012"]}, {"Citation": "Katke S.A., Amrutkar S.V., Bhor R.J., Khairnar M.V. Synthesis of biologically active 2-chloro-N-alkyl/aryl acetamide derivatives. Inter. J. Pharma. Sci. Res. 2011;2:148\u2013156."}, {"Citation": "Kim B., Ratnayake R., Lee H., Shi G., Zeller S.L., Li C., Luesch H., Hong J. Synthesis and biological evaluation of largazole zinc-binding group analogs. Bioorg. Med. Chem. 2017", "ArticleIdList": ["PMC5494147", "28416100"]}, {"Citation": "Lorke D. A new approach to practical acute toxicity testing. Arch. Toxicol. 1983;54:275\u2013287.", "ArticleIdList": ["6667118"]}, {"Citation": "Maggio B., Daidone G., Raffa D., Plescia S., Mantione L., Cutuli V.M.C., Mangano N.G., Caruso A. Synthesis and pharmacological study of ethyl 1-methyl-5-(substituted 3,4-dihydro-4-oxoquinazolin-3-Yl)-1h-pyrazole-4-acetates. Europ. J. Med. Chem. 2001;36:737\u2013742.", "ArticleIdList": ["11672883"]}, {"Citation": "Nagao-Kitamoto H., Kamada N. Host-microbial cross-talk in inflammatory bowel disease. Immune. Netw. 2017;17:1\u201312.", "ArticleIdList": ["PMC5334117", "28261015"]}, {"Citation": "Park E.Y., Kim J.I., Leem D.G., Shin J.S., Kim K.T., Choi S.Y., Lee M.H., Choi J.H., Lee Y.S., Lee K.T. Resveratrol analogue (E)-8-Acetoxy-2-[2-(3,4-diacetoxyphenyl)ethenyl]-quinazoline induces apoptosis via fas-mediated pathway In Hl-60 human leukemia cells. Oncol. Rep. 2016;36:3577\u20133587.", "ArticleIdList": ["27748905"]}, {"Citation": "Patel P., Pillai J., Darji N., Patel B. Recent advance in anti inflammatory activity of benzothiazole derivatives. Int. J. Drug Res. Technol. 2012;2:170\u2013176."}, {"Citation": "Ruan J., Chen Y., Zhou Y. Development and validation of a questionnaire to assess the quality of life in patients with inflammatory bowel disease in mainland China. Inflam. Bowel Diseas. 2017;23:431\u2013439.", "ArticleIdList": ["28129287"]}, {"Citation": "Sawant R., Kawade D. Synthesis and biological evaluation of some novel 2-phenyl benzimidazole-1-acetamide derivatives as potential anthelmintic agents. Acta Pharm. 2011;61:353\u2013361.", "ArticleIdList": ["21945914"]}, {"Citation": "Soliman G.A., Donia Ael R., Awaad A.S., Alqasoumi S.I., Yusufoglu H. Effect of emex spinosa, leptadenia pyrotechnica, haloxylon salicornicum and ochradenus baccatus extracts on the reproductive organs of adult male rats. Pharm. Biol. 2012;50:105\u2013112.", "ArticleIdList": ["22196585"]}]}], "History": [{"Year": "2017", "Month": "7", "Day": "16"}, {"Year": "2017", "Month": "9", "Day": "27"}, {"Year": "2018", "Month": "1", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "1", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "1", "Day": "31", "Hour": "6", "Minute": "1"}, {"Year": "2017", "Month": "9", "Day": "28"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29379346", "PMC5783812", "10.1016/j.jsps.2017.09.011", "S1319-0164(17)30167-6"]}}]}